This document provides an overview of metabolic acidosis. It defines metabolic acidosis as a process that increases hydrogen ions or decreases pH due to accumulation of acid in the body. The main causes discussed are diabetic ketoacidosis, lactic acidosis, renal failure, methanol poisoning, diarrhea, and renal tubular acidosis. Compensation and treatment methods such as sodium bicarbonate administration are also reviewed. Blood gas analysis is described as a key tool to identify the primary acid-base disturbance, compensatory responses, and calculate the anion gap to help diagnose the specific cause of metabolic acidosis.
Short Review regarding Metabolic Acidosis
The Causes, anion gap,urine osmolal gap, Renal Tubular Acidosis, approach to Metabolic Acidosis in Final Slide
one can learn the step by step approach of ABG interpritation and its analysis from basics with the help of different case scenarios,Ref-NEJM article regarding physiological approach to acid base disbalance
Short Review regarding Metabolic Acidosis
The Causes, anion gap,urine osmolal gap, Renal Tubular Acidosis, approach to Metabolic Acidosis in Final Slide
one can learn the step by step approach of ABG interpritation and its analysis from basics with the help of different case scenarios,Ref-NEJM article regarding physiological approach to acid base disbalance
this slide focuses on all the acid base disorder pertaining to the respiratory system. it focus on the compensatory mechanism, causes, clinical features and treatment.
this slide focuses on all the acid base disorder pertaining to the respiratory system. it focus on the compensatory mechanism, causes, clinical features and treatment.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
3. Objectives
We will learn the following topics:
O Metabolic Acidosis
O Definition
O Causes
O Investigations
O Management
O Interpretation of Blood Gas Analysis
O Simple and Mixed Acid-Base Disorders
5. Acidemia vs Acidosis
O Acidemia: when blood pH <7.35
O Acidosis: is a process that increases [H+]
or process which tends to ↓pH
(accumulation of acid in body)
6.
7. O Mechanism:
O gain of H+
O loss of HCO3
O Results in:
O ↓pH (7.35)
O ↓HCO3- (<22mEq/L)
O pCO2 depends on compensation
8. Compensation in
Metabolic Acidosis
O Hyper-ventilation to ↓ PaCO2= Kasmaul
Breathing
O The maximal compensation takes 12 to 24
hours
O The increase in ventilation usually starts
within minutes, usually well advances at 2
hours of onset, but maximal compensation
may take 12 to 24 hours to develop.
O Compensation can never normalize pH, it
can improve it.
9.
10. Anion Gap
O Anion gap = ([Na+] ) − ( [Cl−] + [HCO3−])
O As sodium is the main extracellular cation,
and chloride and bicarbonate are the main
anions, the result should reflect the
remaining anions.
11.
12. O Normally, this concentration is about 8-16
mmol/l (12±4).
O An elevated anion gap (i.e. > 16 mmol/l)
can indicate particular types of metabolic
acidosis, particularly certain poisons,
lactate acidosis and ketoacidosis.
15. High Anion Gap
Metabolic Acidosis
O M-Methanol
O U-Uremia (chronic kidney failure)
O D-Diabetic ketoacidosis
O P-Propylene glycol
O I- Infection, Iron, Isoniazid, Inborn errors
of metabolism
O L-Lactic acidosis
O E-Ethylene glycol
16. High Anion Gap
Metabolic Acidosis
O Endogenous
O Ketoacidosis
O Diabetic
O Alcoholic
O Starvation
O Lactic acidosis
O Uremia
O Exogenous
O Methanol
Ingesion
O Ethanol
O Ethylene glycol
O Isoniazid
O Salicylates
poisoning
17. Normal Anion Gap
Metabolic Acidosis
O Bicarbonate loss through Gut
O Diarrhea
O Pancreatic fistula
O Uretero-sigmoidostomy
O Bicarbonate loss through Kidney
O Renal tubular acidosis
O Carbonic anhydrase inhibtors
O Post-hypocapnea
18. Diabetic Ketoacidosis
O Due to the overproduction of ketone bodies
(Ketosis) leading to accumulation of ketones
in plasma (Ketonemia) and urine (Ketonuria).
O In starvation states where plasma glucose
levels are low or in states of low plasma
insulin where uptake of glucose by cells is
diminished, fatty acids will be mobilized and
transported to tissues (brain, skeletal muscle,
heart) for fatty acid oxidation and energy
production.
19. Diabetic Ketoacidosis
O Acetyl CoA from fatty acid oxidation can
not be oxidized and is instead converted
to the generation of ketone bodies.
(acetoacetate and β-hydroxybutyrate)
which serve as a source of fuel.
20. Lactic Acidosis
O Dead-end product of glycolysis
O Occurs when the body must regenerate ATP
without oxygen
O Normal lactic level is maintained at 0.7-1.3
mEq/L
O Eliminated in liver (50%), kidneys (25%), heart
and skeletal muscles
O Normal Lactate/Pyruvate ratio suggest that
the cause is not related to anaerobic
metabolism or anoxia
21. Lactic Acidosis
O Serum lactate > 5 mEq/L
O Typte1 hypoxia+peripheral generation of
Lactate in patient with circulatory failure+
shock.
O Type2 impaired metabolism of lactate in
liver disease and drug+toxin inhibit lactate
metabolism(eg:metformin)
22. Metabolic Acidosis in Renal
Failure
O Normal AG acidosis results from failure of
the kidney to generate new HCO3- from a
reduced rate of synthesis and excretion of
NH4+ (usually GFR 20-50ml/min)
O Increased AG acidosis results from the
reduced GFR, with accumulation of
sulfates, urates and phosphates. (usually
GFR <15-20ml/min)
23. Methanol Poisoning
O Methanol is metabolized by alcohol
dehydrogenase to formaldehyde and then
to formic acid
O High AG: formic acid, lactic acid, and
ketoacid
O Formaldehyde: optic nerve and CNS
toxicity
O Retinal edema, CNS depression, and
unexplained metabolic acidosis with high
anion and osmolar gaps
24. Normal Anion Gap
Metabolic Acidosis
O Two main causes
O 1. Renal
O 2. Extra-renal
Urinary Anion Gap= Na+ + K+ – Cl- = 0
If positive = Renal
If negative = Extra-renal
25. Metabolic Acidosis in
Severe Diarrhea
O It is when the bowel movement occurs
more than 5 times a day.
O The person loses a great amount of
bicarbonate ions in the stool and therefore
the amount of anions decreases.
O Bicarbonate ions are important for the
blood buffer system.
O Due loss of these ions the buffer system
cannot work properly thus making the
blood acidic.
26. Renal Tubular Acidosis
O •Inability of the kidney to reabsorb the
filtered HCO3
O Inability of the kidney to excrete NH4+
27. Types of RTA
O Type 1 RTA: Distal RTA
O Type 2 RTA: Proximal RTA
O Type 4 RTA: Hyperkalemic
28.
29. Type 1 (distal) RTA
O Defective H+ ion secretion by
α-intercalated cells in late DCT &
CT → ↑H+ ions (acidemia)
O Nephrolithiasis (calcium phosphate
stones) is frequently associated with
untreated type 1 RTA.
O Causes:
O Sjogren’s syndrome, SLE, liver
cirrhosis, and toxins (e.g. amphotericin
B, lithium)
30. Type 2 (proximal) RTA
O Impaired HCO3– reabsorption in PCT →
↑ HCO3– loss in urine → ↑ Blood acidity
O Associated with:
O Multiple myeloma, Fanconi syndrome,
and toxins (e.g. Acetazolamide,
outdated tetracycline)
31. Type 4 (hyperkalemic) RTA
O Aldosterone deficiency/resistance in
Collecting Tubules
O Cause:
O Addison’s disease, diabetic
nephropathy, sickle cell disease, and
drugs (e.g. trimethoprim, NSAIDs, ACE
inhibitors, spironolactone).
32.
33. Consequences of Acidemia on
various Organ System
O Cardiovascular System:
O ↓ contractility
O Arterial vasodilatation
O ↓MAP
O ↓CO
O ↓ response to Catecholamine
O ↑ risk of arrhythmias
34. Consequences of Acidemia on
various Organ System
O Respiratory System:
O Hyperventilation(compensatory)
O ↓ Respiratory Muscle Strength
O Neurological:
O Cerebral Vasodilation → ↑ ICP
35. Consequences of Acidemia on
various Organ System
O Metabolic:
O ↑ Potassium (Due to H+/K+ pump
exchanging excess H+ with Intracellular
K+)
O ↑ Bone resoprtion (In chronic cases)
O ↑ Phosphate concentration in extracellular
fluid
36. Sign & Symptoms
O Neurological:
O Headache
O Drowsiness
O Comatose
O Seizures
O Cardiovascular:
O Tachycardia
O Arrythmia
O Hypotension
37. Sign & Symptoms
O Respiratory:
O Shortness of breath
O Deep and rapid breathing
O Coughing
O Gastric:
O Nausea
O Vomiting
O Diarrhea
38. Sign & Symptoms
O Muscular:
O Cramps
O Seizures
O Generalzied Weakness
39.
40. Investigations
O Blood Gas Analysis (VBGs or ABGs)
O Blood Glucose Level
O Serum Electrolytes
O Serum Ketones (or Urine Ketones)
O Serum Lactates
O Urea and Creatinine
O ECG
43. Management
O Emergency Management:
O Intubation and ventilation for airway or
ventilatory control;
O Cardiopulmonary resuscitation; severe
hyperkalaemia
O Treat Undelying Cause:
O Treat the underlying disorder as the primary
therapeutic goal.
O Consequently,accurate diagnosis of the cause
of the metabolic acidosis is very important.
44. Management
O Replace Losses:
O Replace losses (e.g. of fluids and
electrolytes) where appropriate.Other
supportive care (oxygen administration)
is useful.
O In most cases, IV sodium bicarbonate
is NOT necessary, NOT helpful, and
may even be harmful so is not
generally recommended.
45. Management
O Specific Treatment:
There are often specific problems or
complications associated with specific
causes or specific cases which require
specific management. For example:
O Ethanol blocking treatment with methanol
ingestion;
O Insulin for diabetic ketoacidosis
O Haemodialysis can remove some toxins
46. Management
O Alkali Therapy: Indicated in
O Normal AG Metabolic Acidosis
O Raised AG Metabolic Acidosis due to non-
metabolizable anions
HCO3
- Deficit= 0.5 x Weight (24-[HCO3
-])
O Severe Acidemia pH <7.0 in case of Raised AG
Metabolic Acidosis (50-100mEq IV NaHCO3
-
over 30-45 minutes)
Reference:
Harrison’s Principles of Internal Medicine
47. Management of DKA
O Correction of fluid loss with intravenous fluids
O Correction of hyperglycemia with insulin
O Correction of electrolyte disturbances,
particularly potassium loss
O Correction of acid-base balance
O Treatment of concurrent infection, if present
48. Management of Lactic
Acidosis
O Intravenous fluid to promote circulation
O Oxygen, delivered with a face mask or
another way
O Positive pressure ventilation to deliver oxygen
to the lungs
O Hemodialysis with bicarbonate
O Individuals who experience lactic acidosis
while exercising can stop what they are doing,
rehydrate by drinking water, and rest.
49. Management of RTA
O Type 1 RTA: NaHCO3 (1-3mEq/kg/d)
O Type 2 RTA: NaHCO3 or KHCO3
(10-15mEq/kg/d)
Thiazide diuretics
O Type 4 RTA: Fludrocortisone
(0.1-0.5mg/d)
Dietary restriction
Furosemide (40-160mg/d)
50. Scenario
O 20 year young male diabetic patient presented
with fever and vomiting for 1 day. He was
drowsy and taking deep and rapid breaths.
ABGs showed following findings:
O pH 7.18
O PaCO2 30mmHg
O PaO2 55mmHg
O HCO3
- 10mmol/L
O Na+ 140mEq/L
O Cl- 90meq/L
O What is the interpretation of ABGs?
51. Blood Gas Analysis
O History taking and physical examination
O Identify the primary disturbance
O Check pH-------- acidemia or alkalemia
O HCO3- & pCO2 analysis---primary
disorder
O Compensatory responses
O Calculate Anion Gap
O Assess delta ratio
O Formulate acid-base diagnosis
52. Blood Gas Analysis
O History taking and physical examination
O Identify the primary disturbance
O Check pH-------- acidemia or alkalemia
O HCO3- & pCO2 analysis---primary
disorder
O Compensatory responses
O Calculate Anion Gap
O Assess delta ratio
O Formulate acid-base diagnosis
53. History taking and physical
examination
O Comprehensive history taking and
physical examination can often give clues
as to the underlying acid-base disorder
54. Blood Gas Analysis
O History taking and physical examination
O Identify the primary disturbance
O Check pH: acidemia or alkalemia
O HCO3- & pCO2 analysis: primary disorder
O Compensatory responses
O Calculate Anion Gap
O Assess delta ratio
O Formulate acid-base diagnosis
55. Identify the Primary Disorder
O Is there alkalemia or acidemia present?
pH < 7.35 acidemia
pH > 7.45 alkalemia
O This is usually the primary disorder
O Remember: an acidosis or alkalosis may be
present even if the pH is in the normal range
(7.35 – 7.45)
O You will need to check the PaCO2, HCO3- and
anion gap
56. Blood Gas Analysis
O History taking and physical examination
O Identify the primary disturbance
O Check pH: acidemia or alkalemia
O HCO3- & pCO2 analysis: primary disorder
O Compensatory responses
O Calculate Anion Gap
O Assess delta ratio
O Formulate acid-base diagnosis
57. Identify the Primary Disorder
O Is the disturbance respiratory or
metabolic?
O What is the relationship between the
direction of change in the pH and the
direction of change in the PaCO2?
O In primary respiratory disorders, the pH
and PaCO2 change in opposite directions;
in metabolic disorders the pH and
PaCO2 change in the same direction.
59. Blood Gas Analysis
O History taking and physical examination
O Identify the primary disturbance
O Check pH: acidemia or alkalemia
O HCO3- & pCO2 analysis: primary disorder
O Compensatory responses
O Calculate Anion Gap
O Assess delta ratio
O Formulate acid-base diagnosis
60. Compensatory Response
O Is there appropriate compensation for the
primary disturbance?
O Usually, compensation does not return the
pH to normal (7.35 – 7.45).
62. Blood Gas Analysis
O History taking and physical examination
O Identify the primary disturbance
O Check pH: acidemia or alkalemia
O HCO3- & pCO2 analysis: primary disorder
O Compensatory responses
O Calculate Anion Gap
O Assess delta ratio
O Formulate acid-base diagnosis
63. Anion Gap
O Calculate the anion gap
O AG= [Na+]-( [Cl-] + [HCO3-] )=12 ± 2
O A normal anion gap is approximately 12
meq/L.
64. Anion Gap
O It is important to remember what the
expected “normal” anion gap for your
patient should be, by adjusting for
hypoalbuminemia.
O Calculate corrected sodium before
measurement of anion gap.
65. Corrected Anion Gap for
Hypoalbuminemia
O Normal Anion Gap is 12±2 mmol/L (at
Serum Albumin level 4g/dL)
O Corrected AG = AG + (2.5 x (4-albumin)
expressed in g/dL
O Every 1g/dL decrease in serum albumin
will decrease 2.5mmol/L of anion gap.
66. Corrected Sodium for
Hyperglycemia
O Corrected Na+ =
measured Na++[1.6(glucose–100)/100]
O Glucose is taken in mg/dL.
O This forumla is according to Katz,1973;
correction factor is 2.4 according to
Hillier,1999.
67. Blood Gas Analysis
O History taking and physical examination
O Identify the primary disturbance
O Check pH: acidemia or alkalemia
O HCO3- & pCO2 analysis: primary disorder
O Compensatory responses
O Calculate Anion Gap
O Assess delta ratio
O Urine anion gap
O Formulate acid-base diagnosis
68. Delta Ratio
O If an increased anion gap is present,
assess the relationship between the
increase in the anion gap and the
decrease in [HCO3-].
O Assess the ratio of the change in the
anion gap (∆AG ) to the change
in [HCO3-] (∆[HCO3-]): ∆AG/∆[HCO3-]
69. Delta Ratio
O Delta ratio = ∆ Anion gap/∆ [HCO3-]
= (AG-12)/(24 - [HCO3-])
Let’s suppose AG=30, [HCO3-]= 6, Then
Delta ratio = 30-12/24-6
Delta ratio = 18/18 = 1
70. Delta Ratio
O This ratio should be between 1.0 and 2.0 if an
uncomplicated anion gap metabolic acidosis is
present.
O If this ratio falls outside of this range, then another
metabolic disorder is present:
O If ∆AG/∆[HCO3-] < 1.0, then a concurrent non-anion
gap metabolic acidosis is likely to be present.
O If ∆AG/∆[HCO3-] > 2.0, then a concurrent metabolic
alkalosis is likely to be present.
71. Scenario
O 20 year young male diabetic patient presented
with fever and vomiting for 1 day. He was
drowsy and taking deep and rapid breaths.
ABGs showed following findings:
O pH 7.18
O PaCO2 30mmHg
O PaO2 55mmHg
O HCO3
- 10mmol/L
O Na+ 140mEq/L
O Cl- 90meq/L
O What is the interpretation of ABGs?
72. Blood Gas Analysis
O History taking and physical examination
O Identify the primary disturbance
O Check pH: acidemia or alkalemia
O HCO3- & pCO2 analysis: primary disorder
O Compensatory responses
O Calculate Anion Gap
O Assess delta ratio
O Formulate acid-base diagnosis
73. Blood Gas Analysis
O History= Suspected DKA
O Identify the primary disturbance
O Check pH: 7.2 (acidemia)
O HCO3- & pCO2 analysis: primary disorder
O Compensatory responses
O Predicted PaCO2 = 1.5x[HCO3
-] + 8 ± 2
O Predicted PaCO2 = 1.5x10 + 8 ± 2 = 23 ± 2
O Measure PaCO2 > Predicted PaCO2 =
Concomitant Respiratory Acidosis
74. Blood Gas Analysis
O Calculate Anion Gap
O AG= Na+ - (Cl- + HCO3
-)
O AG= 140 – (90+10) = 140-100= 40
O Assess delta ratio
O Delta ratio = ∆ Anion gap/∆ [HCO3-]
= (AG-12)/(24 - [HCO3-])
=40-12/24-10
=28/14
=2 ( Concomitant Met.Alkalosis)
75. Blood Gas Analysis
O PaO2 = 55mmHg which is <60mmHg
meaning Respiratory Failure
O Formulate acid-base diagnosis
Raised AG Metabolic Acidosis +
Metabolic Alkalosis +
Respiratory Acidosis and
Type II Respiratory Failure